Invention Application
- Patent Title: SOLUBILIZED MAGNOLOL ANALOGS
- Patent Title (中): 溶解的Magnnolol模拟
-
Application No.: US14362903Application Date: 2011-12-15
-
Publication No.: US20140328772A1Publication Date: 2014-11-06
- Inventor: Regina Hourigan , Jeffrey Mastrull , Jairajh Mattai , James Masters
- Applicant: Regina Hourigan , Jeffrey Mastrull , Jairajh Mattai , James Masters
- Applicant Address: US NY New York
- Assignee: COLGATE-PALMOLIVE COMPANY
- Current Assignee: COLGATE-PALMOLIVE COMPANY
- Current Assignee Address: US NY New York
- International Application: PCT/US2011/065021 WO 20111215
- Main IPC: A01N31/08
- IPC: A01N31/08 ; A61K8/49 ; A61Q11/02 ; A61Q19/10 ; A01N25/02 ; A61K8/34 ; A61Q11/00
Abstract:
A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti -bacterial activity and reducing the expression of pro-inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate.
Public/Granted literature
- US09414587B2 Solubilized magnolol analogs Public/Granted day:2016-08-16
Information query
